Cutia Therapeutics (HKG:2487)

Cutia Therapeutics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-433.81	-1,964	-555.84	-319.58
Depreciation & Amortization	42.9	41.47	18.7	9.79
Other Amortization	1.66	1.01	0.22	-
Loss (Gain) From Sale of Assets	0.36	0.25	-	-
Loss (Gain) From Sale of Investments	-21.56	-1.72	-7.68	5.2
Stock-Based Compensation	68.62	132.35	100.03	41.11
Other Operating Activities	0.66	1,415	237.48	137.65
Change in Accounts Receivable	-37.4	-62.85	-0.1	-
Change in Inventory	-32.82	-25.32	-18.19	-1.8
Change in Accounts Payable	-13.84	64.8	21.56	0.42
Change in Unearned Revenue	-0.4	-	-	-
Change in Other Net Operating Assets	-17.36	17.94	-32.37	-32.66
Operating Cash Flow	-442.98	-381.31	-236.19	-159.88
Capital Expenditures	-22.57	-55.73	-134.35	-24.32
Sale of Property, Plant & Equipment	0.01	0.01	-	-
Sale (Purchase) of Intangibles	-3.11	-0.18	-0.96	-1.57
Investment in Securities	328.59	-176.13	609.02	-375.05
Other Investing Activities	13.15	28.46	-11.64	-9.71
Investing Cash Flow	316.07	-203.58	462.07	-410.65
Long-Term Debt Issued	203.45	189.2	-	-
Long-Term Debt Repaid	-143.11	-11.57	-6.88	-3.09
Net Debt Issued (Repaid)	60.34	177.63	-6.88	-3.09
Issuance of Common Stock	4.74	422.52	-	-
Repurchase of Common Stock	-13.86	-	-	-
Other Financing Activities	-13.39	-11.83	-3.37	-0.15
Financing Cash Flow	37.84	588.32	-10.25	480.76
Foreign Exchange Rate Adjustments	1.62	3.82	47.11	-7.27
Net Cash Flow	-87.45	7.25	262.74	-97.04
Free Cash Flow	-465.56	-437.04	-370.54	-184.2
Free Cash Flow Margin	-166.50%	-317.56%	-3260.10%	-9038.08%
Free Cash Flow Per Share	-1.52	-2.14	-4.63	-2.30
Cash Interest Paid	7.4	1.8	-	-
Levered Free Cash Flow	-291.48	-250.48	-203.12	-
Unlevered Free Cash Flow	-284.69	-247.68	-202.04	-
Change in Working Capital	-101.81	-5.42	-29.1	-34.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.